1. Home
  2. GSIW vs MODD Comparison

GSIW vs MODD Comparison

Compare GSIW & MODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GSIW

Garden Stage Limited

HOLD

Current Price

$35.33

Market Cap

33.5M

Sector

N/A

ML Signal

HOLD

Logo Modular Medical Inc.

MODD

Modular Medical Inc.

HOLD

Current Price

$4.17

Market Cap

28.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GSIW
MODD
Founded
2016
1998
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
33.5M
28.5M
IPO Year
2022
2019

Fundamental Metrics

Financial Performance
Metric
GSIW
MODD
Price
$35.33
$4.17
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
5.4K
21.9K
Earning Date
08-04-2026
02-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
34.62
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.05
$0.12
52 Week High
$38.55
$6.16

Technical Indicators

Market Signals
Indicator
GSIW
MODD
Relative Strength Index (RSI) 63.78 57.43
Support Level $0.11 $4.31
Resistance Level $36.90 $5.89
Average True Range (ATR) 3.08 0.63
MACD -0.03 -0.02
Stochastic Oscillator 73.00 73.94

Price Performance

Historical Comparison
GSIW
MODD

About GSIW Garden Stage Limited

Garden Stage Ltd is a Hong Kong-based financial services provider principally engaged in the provision of placing and underwriting services; securities dealing and brokerage services; and asset management services. Its business is carried out through its wholly owned Operating Subsidiaries: I Win Securities, which is licensed to conduct Type 1 (dealing in securities) regulated activities under the SFO in Hong Kong; and I Win Asset Management, which is licensed to conduct Type 4 (advising on securities) and Type 9 (asset management) regulated activities under the SFO in Hong Kong.

About MODD Modular Medical Inc.

Modular Medical Inc is a development stage medical device company which focuses on the design, development, and commercialization of insulin pumps using modernized technology to increase pump adoption in the diabetes marketplace. The company's products seek to serve both the type 1 and the rapidly growing, especially in terms of device adoption, type 2 diabetes markets.

Share on Social Networks: